# Glycopyrrolate

## Glycopyrodyn inj 0.2mg/1mL

#### 一般可用

| 藥品代碼       | IGLYC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Preoperatively to inhibit salivation & excessive secretions of the respiratory tract; reversal of neuromuscular blockade; control of upper airway secretions; adjunct in treatment of peptic ulcer.                                                                                                                                                                                                                                                                                                                                                                                    |
| 用法用量       | Preoperative Adult & children 1 month-12 years 0.002 mg/pound body weight (0.01 mL) IM 30-60 mins before procedure or to be administered with preanesthetic narcotic & sedative. children 1 month-2 years may incresed 0.004 mg/pound body weight (0.02 mL).Intraoperative Adult 0.1 mg (0.5 mL) IV. May repeat at intervals of 2-3 mins. Children 0.002 mg/pound body weight (0.01 mL) IV. Max: 0.1 mg (0.5 mL)/dose. May repeat at intervals of 2-3 minsReversal of neuromuscular blockade Adult & children 0.2 mg (1 mL) IV for each 1 mg of neostigmine or 5 mg of pyridostigmine. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌           | In management of peptic ulcer， may be C/I in glaucoma; obstructive uropathy; achalasia; pyloroduodenal stenosis; paralytic ileus; intestinal atony in the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis. Inj Newborn infant <1 mth.                                                                                                                                                                                                               |
| 副作用         | Dry mouth; urinary hesitancy & retention; blurred vision. Increased ocular tension; tachycardia; palpitations; decreased sweating， loss of taste， headache， nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; impotence; suppression of lactation; constipation; bloated feeling; severe allergic reaction， drug idiosyncrasies; urticaria; mental confusion.                                                                                                                                                                                              |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

